Medicalgorithmics Statistics

Total Valuation

Medicalgorithmics has a market cap or net worth of PLN 201.24 million. The enterprise value is 193.81 million.

Market Cap	201.24M
Enterprise Value	193.81M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Medicalgorithmics has 9.95 million shares outstanding. The number of shares has increased by 21.53% in one year.

Current Share Class	n/a
Shares Outstanding	9.95M
Shares Change (YoY)	+21.53%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	13.82%
Float	4.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.75
PB Ratio	2.41
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.05
EV / Sales	5.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-22.95

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.04.

Current Ratio	2.63
Quick Ratio	1.65
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.37
Interest Coverage	-135.10

Financial Efficiency

Return on equity (ROE) is -11.47% and return on invested capital (ROIC) is -7.57%.

Return on Equity (ROE)	-11.47%
Return on Assets (ROA)	-6.17%
Return on Capital (ROIC)	-7.57%
Revenue Per Employee	291,900
Profits Per Employee	-84,800
Employee Count	120
Asset Turnover	0.30
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.70% in the last 52 weeks. The beta is 0.51, so Medicalgorithmics's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-23.70%
50-Day Moving Average	22.59
200-Day Moving Average	26.01
Relative Strength Index (RSI)	38.80
Average Volume (20 Days)	14,652

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicalgorithmics had revenue of PLN 35.03 million and -10.18 million in losses. Loss per share was -1.03.

Revenue	35.03M
Gross Profit	7.46M
Operating Income	-11.35M
Pretax Income	-10.24M
Net Income	-10.18M
EBITDA	-10.78M
EBIT	-11.35M
Loss Per Share	-1.03

Full Income Statement

Balance Sheet

The company has 10.58 million in cash and 3.13 million in debt, giving a net cash position of 7.44 million or 0.75 per share.

Cash & Cash Equivalents	10.58M
Total Debt	3.13M
Net Cash	7.44M
Net Cash Per Share	0.75
Equity (Book Value)	83.49M
Book Value Per Share	8.39
Working Capital	17.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.07 million and capital expenditures -379,000, giving a free cash flow of -8.45 million.

Operating Cash Flow	-8.07M
Capital Expenditures	-379,000
Free Cash Flow	-8.45M
FCF Per Share	-0.85

Full Cash Flow Statement

Margins

Gross margin is 21.31%, with operating and profit margins of -32.40% and -29.05%.

Gross Margin	21.31%
Operating Margin	-32.40%
Pretax Margin	-29.24%
Profit Margin	-29.05%
EBITDA Margin	-30.78%
EBIT Margin	-32.40%
FCF Margin	-24.11%

Dividends & Yields

Medicalgorithmics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.53%
Shareholder Yield	-21.53%
Earnings Yield	-5.09%
FCF Yield	-4.20%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicalgorithmics has an Altman Z-Score of 5.01.

Altman Z-Score	5.01
Piotroski F-Score	n/a